Nkarta, Inc. (NKTX) - Dilution Analysis
Visualizing historical and potential share dilution over time
Dilution Analysis
Risk Assessment Details
Summary
NKTX currently has 74.3M outstanding shares. with minimal authorized share overhang for future dilution. The company has minimally diluted shareholders by 9.52% over the past 2 years.
Share Structure Timeline
Historical Data Points
| Date | Event | Outstanding | Supply |
|---|---|---|---|
| May 12, 2026 |
10-Q filing | 74.3M shares outstanding |
74M | 0 |
| Mar 25, 2026 |
S-3 filing: Nkarta, Inc. is filing an S-3 to offer common stock, preferred stock, and debt securities for an aggregate offering price not to exceed $350,000,000. |
74M | 0 |
| Mar 25, 2026 |
10-K filing | 74.0M shares outstanding |
74M | 0 |
| Nov 10, 2025 |
10-Q filing | 74.0M shares outstanding |
74M | 0 |
| Aug 12, 2025 |
10-Q filing | 74.0M shares outstanding |
74M | 0 |
| May 14, 2025 |
10-Q filing | 73.9M shares outstanding |
74M | 0 |
| Mar 26, 2025 |
10-K filing | 67.9M shares outstanding |
68M | 0 |
| Nov 07, 2024 |
10-Q filing | 73.6M shares outstanding |
74M | 0 |
| Aug 13, 2024 |
10-Q filing | 73.5M shares outstanding |
73M | 0 |
| May 09, 2024 |
10-Q filing | 70.5M shares outstanding |
70M | 0 |
| Mar 28, 2024 |
8-K filing: Nkarta, Inc. completed an offering of 21,010,000 shares of common stock at $10.00 per share and pre-funded warrants to purchase 3,000,031 shares at $9.9999 per warrant, resulting in net proceeds of approximately $225.2 million. |
49M | 0 |
| Mar 21, 2024 |
10-K filing | 49.0M shares outstanding |
49M | 0 |
| Nov 09, 2023 |
10-Q filing | 49.1M shares outstanding |
49M | 0 |
| Aug 10, 2023 |
10-Q filing | 49.0M shares outstanding |
49M | 0 |
| May 11, 2023 |
10-Q filing | 48.9M shares outstanding |
49M | 0 |
| Apr 24, 2023 |
S-3/A filing: Nkarta, Inc. files an S-3/A form to offer common stock, preferred stock, and debt securities up to an aggregate offering price of $350,000,000. |
49M | 0 |
| Mar 17, 2023 |
S-3 filing: Nkarta, Inc. files an S-3 form to offer common stock, preferred stock and debt securities up to an aggregate offering price of $350,000,000. |
49M | 0 |
| Mar 16, 2023 |
10-K filing | 48.9M shares outstanding |
49M | 0 |
| Nov 09, 2022 |
10-Q filing | 48.6M shares outstanding |
49M | 0 |
| Aug 11, 2022 |
10-Q filing | 43.8M shares outstanding |
44M | 0 |
| May 12, 2022 |
10-Q filing | 48.4M shares outstanding |
48M | 0 |
| Apr 28, 2022 |
8-K filing: Nkarta, Inc. completed an offering of 15,333,334 shares of common stock at $15.00 per share, resulting in net proceeds of approximately $215.5 million, which will be used to fund clinical development, preclinical studies, and internal manufacturing capabilities. ($230.0M proceeds) |
33M | 0 |
| Mar 17, 2022 |
10-K filing | 33.0M shares outstanding |
33M | 0 |
| Nov 10, 2021 |
10-Q filing | 32.9M shares outstanding |
33M | 0 |
| Aug 12, 2021 |
10-Q filing | 32.9M shares outstanding |
33M | 0 |
| Aug 12, 2021 |
S-3 filing: Nkarta, Inc. files an S-3 to offer common stock, preferred stock, and debt securities up to an aggregate amount of $500,000,000. They have also entered into a sales agreement with Cowen to sell up to $150,000,000 of common stock. |
33M | 0 |
| May 13, 2021 |
10-Q filing | 32.8M shares outstanding |
33M | 0 |
| Mar 25, 2021 |
10-K filing | 32.8M shares outstanding |
33M | 0 |
| Nov 12, 2020 |
10-Q filing | 32.6M shares outstanding |
33M | 0 |
| Aug 20, 2020 |
10-Q filing | 32.7M shares outstanding |
33M | 0 |
| Jul 09, 2020 |
S-1/A filing: This is an S-1/A filing for NKARTA, INC. listing Cowen, Evercore ISI, Stifel, and Mizuho Securities as underwriters. |
N/A | 0 |
| Jul 09, 2020 |
S-1/A filing: This is an S-1/A filing for NKARTA, INC. including underwriters Cowen, Evercore ISI, Stifel and Mizuho Securities. |
N/A | 0 |